Together, these results suggest that ALK signaling is already active in pre-tumor stages and leads to an early activation of pSTAT3 and elevated expression of DNMT1 culminating in ALK-dependent transformation in NPM-ALK transgenic mice, which is accompanied by up-regulation of cell cycle genes and c-MYC induction. Here, ALK is linked to neoplasm.